RxDoctor Payments Data

Michael Goldberg, MD

Surgery · Wilmington, DENPI 1114206752

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (44.9%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Intuitive Surgical at 53.2% of the total. Reporting peaked in 2019 at $1,388 and has fallen 74.0% since, to $361 in 2024.

$2,764in general payments, 2019–2025

Across 31 payments — averaging $89.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$1K
  • BD$400
  • Medtronic$388
  • AbbVie$353
  • Zimmer Biomet$41
  • Novo Nordisk$35
  • plus $76 from 5 others

What the payments were for

  • Speaking & faculty fees$40014%
  • Travel & lodging$1,12341%
  • Food & beverage$1,24145%

General payments by program year

19
20
21
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Intuitive Surgical16$1,472
BD1$400
Medtronic3$388
AbbVie(2 entities)2$353
Zimmer Biomet1$41
Novo Nordisk3$35
Johnson & Johnson1$23
TEI Biosciences Inc1$14
KCI USA, Inc.1$14
Covidien LP1$13
Foundation Medicine, Inc.1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,764 in reported general payments places this provider in the 55th percentile of 89 surgery providers in Delaware.

See all surgery providers in Delaware

Medicare billing

Part B allowed, 2024
$64,838
Medicare patients
195
Services billed
357

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Omeprazole16$345

Paid to pharmacies, not to this prescriber.

Other surgery in Wilmington

See the full list for Delaware

Where these figures come from

Is this you, or does something look wrong? →